Pharmaceutical preparations

Connect

Perspectives 26 Apr 2021

Should we be routinely co‐prescribing naloxone for patients on long term opioids?

Pallavi Prathivadi and Suzanne Nielsen

Med J Aust 2021; 214 (9): 403-404.e1

Research 19 Apr 2021

The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain

Bronwyn Bebee, David M Taylor, Elyssia Bourke, Kimberley Pollack, Lian Foster, Michael Ching and Anselm Wong

Med J Aust 2021; 214 (8): 370-375 Free

Systematic reviews 5 Apr 2021

The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews

Christina Abdel Shaheed, Giovanni E Ferreira, Alissa Dmitritchenko, Andrew J McLachlan, Richard O Day, Bruno Saragiotto, Christine Lin, Vicki Langendyk, Fiona Stanaway, Jane Latimer, Steven Kamper, Hanan McLachlan, Harbeer Ahedi and Christopher G Maher

Med J Aust 2021; 214 (7): 324-331 Free

Letters 5 Apr 2021

Confusion about doxylamine safety in pregnancy

Debra S Kennedy and Ronald P Batagol

Med J Aust 2021; 214 (6): 286-286.e1

Perspectives 22 Mar 2021

Screening for hydroxychloroquine retinopathy in Australia

Marisse T Sonido, Kristopher Rallah-Baker and Monisha Gupta

Med J Aust 2021; 214 (7): 301-302.e1

Editorials 15 Feb 2021

Biosimilars: is interchangeability the proof of the pudding?

Gregory T Moore and Charlotte Keung

Med J Aust 2021; 214 (3): 124-125

Research letters 8 Feb 2021

Residential medication management reviews in Australian residential aged care facilities

Janet K Sluggett, J Simon Bell, Catherine Lang, Megan Corlis, Craig Whitehead, Steven L Wesselingh and Maria C Inacio

Med J Aust 2021; 214 (9): 432-433 Free

Letters 1 Feb 2021

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Peter S Hamblin, Rosemary Wong and Leon A Bach

Med J Aust 2021; 214 (2): 94-94.e1

Perspectives 1 Feb 2021

Putting the “good” into Good Clinical Practice

Tanya Symons, Steve Webb and John R Zalcberg

Med J Aust 2021; 214 (2): 62-65.e1

Letters 1 Feb 2021

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Emily J Meyer, Venkatesan Thiruvenkatarajan and David Jesudason

Med J Aust 2021; 214 (2): 93-93.e1

Medical history 23 Nov 2020

Meningitis and the military: the remarkable story of the first use of penicillin in Australia (1943)

Ameneh Khatami, Philip N Britton, Glendon Farrow, Megan Phelps and Alyson Kakakios

Med J Aust 2020; 213 (11): 508-510.e1

Research 9 Nov 2020

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study

Craig Haifer, Ashish Srinivasan, Yoon‐Kyo An, Sherman Picardo, Daniel Langenberg, Shankar Menon, Jakob Begun, Simon Ghaly and Lena Thin

Med J Aust 2021; 214 (3): 128-133 Free

Editorials 2 Nov 2020

Opioid stewardship can reduce inappropriate prescribing of opioids at hospital discharge

Stephan A Schug

Med J Aust 2020; 213 (9): 409-410

Research 26 Oct 2020

Educating junior doctors and pharmacists to reduce discharge prescribing of opioids for surgical patients: a cluster randomised controlled trial

Ria E Hopkins, Thuy Bui, Alex H Konstantatos, Carolyn Arnold, Dianna J Magliano, Danny Liew and Michael J Dooley

Med J Aust 2020; 213 (9): 417-423 Free

Editorials 5 Oct 2020

Red‐flagging the prescribing of oral corticosteroids for people with asthma

Christine F McDonald and Christopher J Worsnop

Med J Aust 2020; 213 (7): 313-314

Letters 3 Aug 2020

Unintended consequences of using real time prescription monitoring systems

Sarah Haines, Michael Savic, Louisa Picco, Suzanne Nielsen and Adrian Carter

Med J Aust 2020; 213 (3): 142-142.e1

Narrative review 20 Jul 2020

Clinical trials for the prevention and treatment of COVID‐19: current state of play

Joshua S Davis, David Ferreira, Justin T Denholm and Steven YC Tong

Med J Aust 2020; 213 (2): 86-93 Free

Research letters 8 Jun 2020

Assessing angiotensin‐converting enzyme (ACE) protein is more appropriate than ACE activity when investigating sarcoidosis

Carel J Pretorius and Jacobus PJ Ungerer

Med J Aust 2020; 213 (4): 178-179 Free

Perspectives 1 Jun 2020

Drug repurposing in the era of COVID‐19: a call for leadership and government investment

Jennifer H Martin and Nikola A Bowden

Med J Aust 2020; 212 (10): 450-452.e1 Free

Medical education / Lessons from practice 25 May 2020

Candida auris in an Australian health care facility: importance of screening high risk patients

Leon J Worth, Simon J Harrison, Michael Dickinson, Annaliese Diemen, Jennifer Breen, Susan Harper, Caroline Marshall, Deborah A Williamson, Karin A Thursky and Monica A Slavin

Med J Aust 2020; 212 (11): 510-511.e1

Letters 18 May 2020